Why clinical trials stop: the role of genetics

Using machine learning to analyse the genetic factors behind early clinical trial termination, researchers find a link between genetic evidence and trial outcome
Open Targets logo
Open Targets. Credit: Karen Arnott/EMBL-EBI

Source article(s)

Related links

Tags: bioinformatics, drug discovery, embl-ebi, genomics, machine learning, open targets,

Share this

More Research highlights